Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|July 6, 2011
Peri-conceptual cytokines--setting the trajectory for embryo implantation, pregnancy and beyondSarah A Robertson, Peck Yin Chin, Danielle J Glynn, et al.Advances in Experimental Medicine and Biology|May 10, 2015
Female tract cytokines and developmental programming in embryosSarah A Robertson, Peck-Yin Chin, John E Schjenken, et al.Journal of Reproductive Immunology|January 7, 2018
Embryotoxic cytokines-Potential roles in embryo loss and fetal programmingSarah A Robertson, Peck-Yin Chin, Joseph G Femia, et al.Current Pharmaceutical Design|February 1, 2018
Toll-like Receptor-4: A New Target for Preterm Labour Pharmacotherapies?Sarah A Robertson, Hanan H Wahid, Peck Yin Chin, et al.Endocrinology|September 11, 2019
Toll-Like Receptor-4 Antagonist (+)-Naloxone Confers Sexually Dimorphic Protection From Inflammation-Induced Fetal Programming in MicePeck Yin Chin, Camilla Dorian, David J Sharkey, et al.Scientific Reports|November 8, 2016
Novel Toll-like receptor-4 antagonist (+)-naloxone protects mice from inflammation-induced preterm birthPeck Yin Chin, Camilla L Dorian, Mark R Hutchinson, et al.JCI Insight|October 8, 2021
Macrophages exert homeostatic actions in pregnancy to protect against preterm birth and fetal inflammatory injuryNardhy Gomez-Lopez, Valeria Garcia-Flores, Peck Yin Chin, et al.Endocrinology|July 8, 2015
Toll-Like Receptor 4 Is an Essential Upstream Regulator of On-Time Parturition and Perinatal Viability in MiceHanan H Wahid, Camilla L Dorian, Peck Yin Chin, et al.Clinical & Translational Immunology|April 22, 2020
Targeting Toll-like receptor-4 to tackle preterm birth and fetal inflammatory injurySarah A Robertson, Mark R Hutchinson, Kenner C Rice, et al.The American Journal of Pathology|February 22, 2020
Toll-Like Receptor-4 Antagonist (+)-Naltrexone Protects Against Carbamyl-Platelet Activating Factor (cPAF)-Induced Preterm Labor in MiceHanan H Wahid, Peck Yin Chin, David J Sharkey, et al.Pageof 2